Foxp3+ regulatory T cells play a protective role in Angiotensin II-induced aortic aneurysm formation in mice

Hypertension

Volumn 65, Issue 4, 2015, Pages 889-895

  Yodoi, Keiko ^a   Yamashita, Tomoya ^a   Sasaki, Naoto ^a   Kasahara, Kazuyuki ^a   Emoto, Takuo ^a   Matsumoto, Takuya ^a   Kita, Tomoyuki ^a   Sasaki, Yoshihiro ^a   Mizoguchi, Taiji ^a   Sparwasser, Tim ^b,c   Hirata, Ken Ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b INSTITUTE OF INFECTION IMMUNOLOGY   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

aortic aneurysm, abdominal; immunology; inflammation; interleukin 2; T lymphocytes, regulatory

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ANTIBODY; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL DIET; CONTROLLED STUDY; CYTOKINE RELEASE; HEART PROTECTION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MALE; MORTALITY; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; ABDOMINAL AORTA; ANIMAL; AORTIC ANEURYSM, ABDOMINAL; C57BL MOUSE; CELLULAR IMMUNITY; CHEMICALLY INDUCED; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANGIOTENSIN II; ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY;

EID: 84929130944     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04934     Document Type: Article

References (28)

1. Golledge J, Muller J, Daugherty A, Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol. 2006; 26: 2605-2613. doi: 10.1161/01.ATV.0000245819.32762.cb
2. Golledge J, Norman PE. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis. 2011; 217: 57-63. doi: 10.1016/j. atherosclerosis.2011.03.006
3. Shimizu K, Mitchell RN, Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2006; 26: 987-994. doi: 10.1161/01.ATV.0000214999.12921.4f
4. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011; 12: 204-212. doi: 10.1038/ni.2001
5. Shimizu K, Shichiri M, Libby P, Lee RT, Mitchell RN. Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. J Clin Invest. 2004; 114: 300-308. doi: 10.1172/JCI19855
6. Schönbeck U, Sukhova GK, Gerdes N, Libby P. T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm. Am J Pathol. 2002; 161: 499-506. doi: 10.1016/S0002-9440(10)64206-X
7. King VL, Lin AY, Kristo F, Anderson TJ, Ahluwalia N, Hardy GJ, Owens AP 3rd, Howatt DA, Shen D, Tager AM, Luster AD, Daugherty A, Gerszten RE. Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture. Circulation. 2009; 119: 426-435. doi: 10.1161/CIRCULATIONAHA.108.785949
8. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008; 133: 775-787. doi: 10.1016/j. cell.2008.05.009
9. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med. 2006; 12: 178-180. doi: 10.1038/nm1343
10. Klingenberg R, Gerdes N, Badeau RM, et al. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J Clin Invest. 2013; 123: 1323-1334. doi: 10.1172/JCI63891
11. Sasaki N, Yamashita T, Takeda M, Hirata K. Regulatory T cells in atherogenesis. J Atheroscler Thromb. 2012; 19: 503-515
12. Wigren M, Björkbacka H, Andersson L, Ljungcrantz I, Fredrikson GN, Persson M, Bryngelsson C, Hedblad B, Nilsson J. Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke. Arterioscler Thromb Vasc Biol. 2012; 32: 2000-2004. doi: 10.1161/ATVBAHA.112.251579
13. Emoto T, Sasaki N, Yamashita T, Kasahara K, Yodoi K, Sasaki Y, Matsumoto T, Mizoguchi T, Hirata K. Regulatory/effector T-cell ratio is reduced in coronary artery disease. Circ J. 2014; 78: 2935-2941
14. Ait-Oufella H, Wang Y, Herbin O, Bourcier S, Potteaux S, Joffre J, Loyer X, Ponnuswamy P, Esposito B, Dalloz M, Laurans L, Tedgui A, Mallat Z. Natural regulatory T cells limit angiotensin II-induced aneurysm formation and rupture in mice. Arterioscler Thromb Vasc Biol. 2013; 33: 2374-2379. doi: 10.1161/ATVBAHA.113.301280
15. Meng X, Yang J, Zhang K, An G, Kong J, Jiang F, Zhang Y, Zhang C. Regulatory T cells prevent angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E knockout mice. Hypertension. 2014; 64: 875-882. doi: 10.1161/HYPERTENSIONAHA.114.03950
16. Yin M, Zhang J, Wang Y, Wang S, Böckler D, Duan Z, Xin S. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2010; 30: 1825-1831. doi: 10.1161/ATVBAHA.109.200303
17. Dinh TN, Kyaw TS, Kanellakis P, To K, Tipping P, Toh BH, Bobik A, Agrotis A. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis. Circulation. 2012; 126: 1256-1266. doi: 10.1161/CIRCULATIONAHA.112.099044
18. Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, Hamann A, Wagner H, Huehn J, Sparwasser T. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med. 2007; 204: 57-63. doi: 10.1084/jem.20061852
19. Kasahara K, Sasaki N, Yamashita T, Kita T, Yodoi K, Sasaki Y, Takeda M, Hirata K. CD3 antibody and IL-2 complex combination therapy inhibits atherosclerosis by augmenting a regulatory immune response. J Am Heart Assoc. 2014; 3: e000719. doi: 10.1161/JAHA.113.000719
20. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000; 105: 1605-1612. doi: 10.1172/JCI7818
21. Maganto-García E, Tarrio ML, Grabie N, Bu DX, Lichtman AH. Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation. 2011; 124: 185-195. doi: 10.1161/CIRCULATIONAHA.110.006411
22. Barhoumi T, Kasal DA, Li MW, Shbat L, Laurant P, Neves MF, Paradis P, Schiffrin EL. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension. 2011; 57: 469-476. doi: 10.1161/HYPERTENSIONAHA.110.162941
23. Kasal DA, Barhoumi T, Li MW, Yamamoto N, Zdanovich E, Rehman A, Neves MF, Laurant P, Paradis P, Schiffrin EL. T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension. 2012; 59: 324-330. doi: 10.1161/HYPERTENSIONAHA.111.181123
24. Kvakan H, Kleinewietfeld M, Qadri F, Park JK, Fischer R, Schwarz I, Rahn HP, Plehm R, Wellner M, Elitok S, Gratze P, Dechend R, Luft FC, Muller DN. Regulatory T cells ameliorate angiotensin II-induced cardiac damage. Circulation. 2009; 119: 2904-2912. doi: 10.1161/CIRCULATIONAHA.108.832782
25. Sasaki N, Yamashita T, Takeda M, Shinohara M, Nakajima K, Tawa H, Usui T, Hirata K. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation. 2009; 120: 1996-2005. doi: 10.1161/CIRCULATIONAHA.109.863431
26. Takeda M, Yamashita T, Sasaki N, Nakajima K, Kita T, Shinohara M, Ishida T, Hirata K. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol. 2010; 30: 2495-2503. doi: 10.1161/ATVBAHA.110.215459
27. Kita T, Yamashita T, Sasaki N, Kasahara K, Sasaki Y, Yodoi K, Takeda M, Nakajima K, Hirata K. Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice. Cardiovasc Res. 2014; 102: 107-117. doi: 10.1093/cvr/cvu002
28. Mallat Z, Gojova A, Brun V, Esposito B, Fournier N, Cottrez F, Tedgui A, Groux H. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation. 2003; 108: 1232-1237. doi: 10.1161/01.CIR.0000089083.61317.A1